DANIEL ERNESTO
CASTELLANO GAUNA

Profesor asociado de Ciencias de la Salud

Foto de DANIEL ERNESTO

Foto de Hospital Universitari de Bellvitge

Hospital Universitari de Bellvitge

l'Hospitalet de Llobregat, España

Publications in collaboration with researchers from Hospital Universitari de Bellvitge (5)

2022

Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34

2018

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Oncologist, Vol. 23, Núm. 4, pp. 422-432

2013

Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. the large experience of the spanish national tumor registry (RGETNE)
Neuroendocrinology, Vol. 98, Núm. 2, pp. 156-168

2012

Recomendations on the management of controversies in advanced castrate-resistant prostate cancer
Actas Urologicas Espanolas, Vol. 36, Núm. 10, pp. 569-577

2010

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)
Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803